| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.696 | 0.009 | 0.696 | Streptokinase A inhibitor | |||
| 0.704 | 0.028 | 0.704 | Transcription factor inhibitor | 0.215 0.213 DBMET00706 | ||
| 0.68 | 0.009 | 0.68 | Thioredoxin glutathione reductase inhibitor | |||
| 0.645 | 0.014 | 0.645 | Antibacterial | 0.432 0.063 DBMET00639 0.463 0.052 DBMET00706 | ||
| 0.545 | 0.011 | 0.545 | Cardiotonic | |||
| 0.564 | 0.068 | 0.564 | DNA polymerase beta inhibitor | |||
| 0.53 | 0.074 | 0.53 | DNA directed DNA polymerase inhibitor | |||
| 0.449 | 0.02 | 0.449 | Hypoxia-inducible factor 1 alpha inhibitor | 0.23 0.119 DBMET00639 0.196 0.156 DBMET00706 | ||
| 0.377 | 0.005 | 0.377 | Heat shock protein 90 antagonist | 0.122 0.111 DBMET00706 | ||
| 0.342 | 0.052 | 0.342 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.156 0.135 DBMET00706 | ||
| 0.31 | 0.021 | 0.31 | Mcl-1 antagonist | |||
| 0.275 | 0.019 | 0.275 | Heat shock protein 90 alpha antagonist | |||
| 0.255 | 0.031 | 0.255 | Amyloid beta precursor protein antagonist | |||
| 0.309 | 0.127 | 0.533 | MAP kinase kinase 6 inhibitor | 0.533 0.012 DBMET00706 | DBMET00706 | |
| 0.152 | 0.007 | 0.152 | Androgen agonist | 0.061 0.04 DBMET00706 | ||
| 0.152 | 0.009 | 0.152 | Thioredoxin reductase inhibitor | 0.123 0.016 DBMET00639 | ||
| 0.174 | 0.044 | 0.225 | Cell wall synthesis inhibitor | 0.225 0.022 DBMET00639 0.139 0.076 DBMET00706 | DBMET00639 | |
| 0.166 | 0.039 | 0.276 | Alkylator | 0.276 0.014 DBMET00639 | DBMET00639 | |
| 0.161 | 0.081 | 0.245 | Catenin beta inhibitor | 0.245 0.012 DBMET00639 | DBMET00639 | |
| 0.138 | 0.058 | 0.183 | Antibacterial (Helicobacter pylori) | 0.183 0.027 DBMET00639 | DBMET00639 | |
| 0.105 | 0.035 | 0.105 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.234 | 0.165 | 0.234 | Beta lactamase inhibitor | |||
| 0.228 | 0.165 | 0.344 | Calpain 2 inhibitor | 0.344 0.089 DBMET00706 | DBMET00706 | |
| 0.078 | 0.02 | 0.107 | Protein 50S ribosomal subunit inhibitor | 0.06 0.031 DBMET00639 0.107 0.012 DBMET00706 | DBMET00706 | |
| 0.245 | 0.19 | 0.277 | Alpha-glucosidase inhibitor | 0.277 0.172 DBMET00706 | DBMET00706 | |
| 0.129 | 0.077 | 0.129 | Alkaline phosphatase inhibitor | 0.108 0.103 DBMET00706 | ||
| 0.149 | 0.097 | 0.251 | Cyclin-dependent kinase 3 inhibitor | 0.251 0.016 DBMET00706 | DBMET00706 | |
| 0.104 | 0.052 | 0.104 | DNA directed RNA polymerase inhibitor | |||
| 0.06 | 0.017 | 0.309 | Cathepsin L2 inhibitor | 0.309 0.004 DBMET00706 | DBMET00706 | |
| 0.096 | 0.056 | 0.096 | Hepatocyte growth factor antagonist | |||
| 0.119 | 0.087 | 0.119 | Toll-Like receptor 9 antagonist | |||
| 0.175 | 0.161 | 0.395 | DNA synthesis inhibitor | 0.395 0.022 DBMET00639 0.248 0.068 DBMET00706 | DBMET00639 | |
| 0.035 | 0.033 | 0.051 | Glutamate (mGluR8) agonist | 0.051 0.011 DBMET00639 | DBMET00639 | |
| 0.055 | 0.055 | 0.069 | Ryanodine receptor antagonist | 0.069 0.019 DBMET00639 | DBMET00639 | |
| 0.109 | 0.114 | 0.192 | Cytidine deaminase inhibitor | 0.15 0.075 DBMET00639 0.192 0.052 DBMET00706 | DBMET00706 | |
| 0.1 | 0.122 | 0.144 | Sphingosine 1-phosphate receptor 4 antagonist | 0.144 0.039 DBMET00639 | DBMET00639 | |
| 0.117 | 0.153 | 0.224 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.224 0.01 DBMET00706 | DBMET00706 | |
| 0.038 | 0.077 | 0.048 | Glucose-6-phosphate translocase inhibitor | 0.048 0.042 DBMET00639 | DBMET00639 | |
| 0.033 | 0.098 | 0.206 | Alpha-mannosidase inhibitor | 0.049 0.047 DBMET00639 0.206 0.003 DBMET00706 | DBMET00706 | |
| 0.016 | 0.083 | 0.034 | Acid ceramidase inhibitor | 0.034 0.005 DBMET00706 | DBMET00706 | |
| 0.064 | 0.14 | 0.12 | MAO inhibitor | 0.12 0.075 DBMET00706 | DBMET00706 | |
| 0.099 | 0.182 | 0.378 | DNA methyltransferase I inhibitor | 0.378 0.011 DBMET00639 | DBMET00639 | |
| 0.021 | 0.111 | 0.176 | Mannosidase inhibitor | 0.176 0.003 DBMET00706 | DBMET00706 | |
| 0.056 | 0.152 | 0.146 | Triose-phosphate isomerase inhibitor | 0.146 0.021 DBMET00639 0.111 0.038 DBMET00706 | DBMET00639 | |
| 0.054 | 0.152 | 0.126 | Creatine kinase inhibitor | 0.089 0.073 DBMET00639 0.126 0.037 DBMET00706 | DBMET00706 | |
| 0.054 | 0.161 | 0.111 | UDP-glucose 4-epimerase inhibitor | 0.106 0.055 DBMET00639 0.111 0.05 DBMET00706 | DBMET00706 | |
| 0.074 | 0.182 | 0.133 | Toll-Like receptor antagonist | 0.133 0.069 DBMET00639 | DBMET00639 | |
| 0.072 | 0.182 | 0.223 | Cathepsin H inhibitor | 0.116 0.08 DBMET00639 0.223 0.017 DBMET00706 | DBMET00706 | |
| 0.043 | 0.162 | 0.113 | Exportin-1 inhibitor | 0.113 0.005 DBMET00639 0.088 0.017 DBMET00706 | DBMET00639 | |
| 0.116 | 0.236 | 0.373 | DNA damaging | 0.373 0.034 DBMET00639 | DBMET00639 | |
| 0.105 | 0.226 | 0.315 | ATPase inhibitor | 0.315 0.005 DBMET00639 | DBMET00639 | |
| 0.139 | 0.273 | 0.242 | 5 Hydroxytryptamine 3E antagonist | 0.167 0.145 DBMET00639 0.242 0.02 DBMET00706 | DBMET00706 | |
| 0.049 | 0.193 | 0.136 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.136 0.032 DBMET00639 0.083 0.077 DBMET00706 | DBMET00639 | |
| 0.024 | 0.168 | 0.085 | Glucose-6-phosphate isomerase inhibitor | 0.085 0.007 DBMET00639 0.061 0.018 DBMET00706 | DBMET00639 | |
| 0.024 | 0.175 | 0.084 | HIV-1 reverse transcriptase inhibitor | 0.084 0.039 DBMET00639 | DBMET00639 | |
| 0.096 | 0.252 | 0.279 | Succinate dehydrogenase inhibitor | 0.279 0.015 DBMET00639 0.18 0.068 DBMET00706 | DBMET00639 | |
| 0.1 | 0.259 | 0.213 | Calpain inhibitor | 0.213 0.101 DBMET00706 | DBMET00706 | |
| 0.008 | 0.176 | 0.037 | Potassium channel small-conductance Ca-activated activator | 0.037 0.017 DBMET00706 | DBMET00706 | |
| 0.03 | 0.2 | 0.066 | Heat shock protein 90 beta antagonist | 0.066 0.032 DBMET00706 | DBMET00706 | |
| 0.134 | 0.308 | 0.487 | Tyrosine 3 hydroxylase inhibitor | 0.487 0.004 DBMET00639 0.282 0.043 DBMET00706 | DBMET00639 | |
| 0.058 | 0.232 | 0.31 | Aldehyde dehydrogenase inhibitor | 0.31 0.011 DBMET00639 | DBMET00639 | |
| 0.127 | 0.301 | 0.195 | Nitric-oxide synthase stimulant | 0.195 0.098 DBMET00639 0.19 0.106 DBMET00706 | DBMET00639 | |
| 0.078 | 0.255 | 0.356 | DNA methylase inhibitor | 0.356 0.016 DBMET00639 | DBMET00639 | |
| 0.018 | 0.199 | 0.152 | Phosphofructokinase-1 inhibitor | 0.152 0.018 DBMET00639 0.079 0.042 DBMET00706 | DBMET00639 | |
| 0.018 | 0.201 | 0.07 | Biliverdin reductase inhibitor | 0.07 0.032 DBMET00639 0.053 0.049 DBMET00706 | DBMET00639 | |
| 0.004 | 0.186 | 0.037 | Thromboxane A2 agonist | 0.037 0.003 DBMET00639 | DBMET00639 | |
| 0.002 | 0.185 | 0.09 | Lysophosphatidic acid receptor 3 agonist | 0.09 0.001 DBMET00639 | DBMET00639 | |
| 0.028 | 0.212 | 0.074 | Potassium channel intermediate-conductance Ca-activated blocker | 0.074 0.023 DBMET00639 0.058 0.045 DBMET00706 | DBMET00639 | |
| 0.058 | 0.241 | 0.295 | Adenylate kinase inhibitor | 0.295 0.007 DBMET00639 0.111 0.052 DBMET00706 | DBMET00639 | |
| 0.011 | 0.199 | 0.056 | Ornithine carbamoyltransferase inhibitor | 0.056 0.034 DBMET00639 | DBMET00639 | |
| 0.051 | 0.24 | 0.301 | Alpha-N-acetylglucosaminidase inhibitor | 0.301 0.016 DBMET00639 0.29 0.017 DBMET00706 | DBMET00639 | |
| 0.108 | 0.304 | 0.4 | Transcription factor STAT3 inhibitor | 0.4 0.018 DBMET00639 | DBMET00639 | |
| 0.018 | 0.215 | 0.124 | Carbamoyl phosphate synthetase inhibitor | 0.124 0.015 DBMET00639 0.105 0.019 DBMET00706 | DBMET00639 | |
| 0.044 | 0.246 | 0.065 | MDM2 inhibitor | 0.065 0.057 DBMET00639 | DBMET00639 | |
| 0.007 | 0.212 | 0.171 | Fumarate hydratase inhibitor | 0.171 0.004 DBMET00639 | DBMET00639 | |
| 0.129 | 0.335 | 0.445 | GABA C receptor rho-3 antagonist | 0.445 0.043 DBMET00639 0.417 0.054 DBMET00706 | DBMET00639 | |
| 0.015 | 0.222 | 0.119 | Alcohol oxidase inhibitor | 0.119 0.014 DBMET00639 0.068 0.03 DBMET00706 | DBMET00639 | |
| 0.039 | 0.246 | 0.322 | GABA C receptor agonist | 0.322 0.008 DBMET00639 0.187 0.023 DBMET00706 | DBMET00639 | |
| 0.044 | 0.253 | 0.152 | Amylase inhibitor | 0.152 0.063 DBMET00639 | DBMET00639 | |
| 0.003 | 0.213 | 0.06 | Carbonic anhydrase X inhibitor | 0.06 0.002 DBMET00639 | DBMET00639 | |
| 0.003 | 0.213 | 0.06 | Carbonic anhydrase VIII inhibitor | 0.06 0.002 DBMET00639 | DBMET00639 | |
| 0.009 | 0.22 | 0.041 | Oxytocin antagonist | 0.041 0.023 DBMET00706 | DBMET00706 | |
| 0.028 | 0.242 | 0.068 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.068 0.064 DBMET00706 | DBMET00706 | |
| 0.095 | 0.314 | 0.193 | 12-Lipoxygenase inhibitor | 0.193 0.16 DBMET00639 | DBMET00639 | |
| 0.006 | 0.233 | 0.066 | Vascular adhesion protein 1 inhibitor | 0.066 0.007 DBMET00706 | DBMET00706 | |
| 0.016 | 0.248 | 0.093 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.093 0.019 DBMET00639 | DBMET00639 | |
| 0.043 | 0.276 | 0.167 | Carbonic anhydrase III inhibitor | 0.167 0.023 DBMET00639 | DBMET00639 | |
| 0.019 | 0.254 | 0.127 | Porphobilinogen synthase inhibitor | 0.127 0.026 DBMET00639 | DBMET00639 | |
| 0.031 | 0.268 | 0.091 | Urease inhibitor | 0.091 0.078 DBMET00639 | DBMET00639 | |
| 0.018 | 0.262 | 0.113 | Na+ K+ transporting ATPase inhibitor | 0.113 0.021 DBMET00639 | DBMET00639 | |
| 0.007 | 0.251 | 0.044 | DNA gyrase subunit B inhibitor | 0.044 0.018 DBMET00706 | DBMET00706 | |
| 0.013 | 0.259 | 0.069 | Argininosuccinate synthase inhibitor | 0.069 0.031 DBMET00639 | DBMET00639 | |
| 0.004 | 0.259 | 0.042 | Kynurenine 3 monooxygenase inhibitor | 0.042 0.009 DBMET00639 | DBMET00639 | |
| 0.019 | 0.274 | 0.12 | Glutamate decarboxylase inhibitor | 0.12 0.021 DBMET00639 0.081 0.043 DBMET00706 | DBMET00639 | |
| 0.002 | 0.258 | 0.023 | Carbonic anhydrase XI inhibitor | 0.023 0.004 DBMET00639 | DBMET00639 | |
| 0.018 | 0.275 | 0.095 | Nitric oxide donor | 0.095 0.011 DBMET00639 | DBMET00639 | |
| 0.046 | 0.306 | 0.148 | DOPA decarboxylase inhibitor | 0.148 0.023 DBMET00639 0.095 0.086 DBMET00706 | DBMET00639 | |
| 0.015 | 0.276 | 0.063 | Carbonic anhydrase V inhibitor | 0.063 0.05 DBMET00639 | DBMET00639 | |
| 0.017 | 0.282 | 0.1 | Kainate receptor agonist | 0.1 0.003 DBMET00639 | DBMET00639 | |
| 0.008 | 0.276 | 0.087 | Lysophosphatidic acid receptor 1 agonist | 0.087 0.002 DBMET00639 | DBMET00639 | |
| 0.024 | 0.295 | 0.103 | Protease 3C (Human rhinovirus) inhibitor | 0.103 0.014 DBMET00639 0.06 0.052 DBMET00706 | DBMET00639 | |
| 0.028 | 0.3 | 0.16 | Glutamate dehydrogenase inhibitor | 0.16 0.014 DBMET00639 | DBMET00639 | |
| 0.007 | 0.287 | 0.025 | Vanilloid 2 agonist | 0.025 0.019 DBMET00639 | DBMET00639 | |
| 0.019 | 0.299 | 0.069 | CYP2A6 inhibitor | 0.069 0.06 DBMET00639 | DBMET00639 | |
| 0.017 | 0.298 | 0.07 | Carbonic anhydrase VA inhibitor | 0.07 0.045 DBMET00639 | DBMET00639 | |
| 0.012 | 0.297 | 0.112 | Lysophosphatidic acid 3 receptor antagonist | 0.112 0.004 DBMET00639 | DBMET00639 | |
| 0.001 | 0.286 | 0.023 | Thromboxane agonist | 0.023 0.004 DBMET00639 | DBMET00639 | |
| 0.015 | 0.3 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.05 0.049 DBMET00639 0.057 0.038 DBMET00706 | DBMET00706 | |
| 0.054 | 0.341 | 0.144 | Thiol protease inhibitor | 0.144 0.075 DBMET00706 | DBMET00706 | |
| 0.058 | 0.345 | 0.362 | Free radical scavenger | 0.362 0.036 DBMET00639 | DBMET00639 | |
| 0.007 | 0.295 | 0.066 | Carbonic anhydrase VB inhibitor | 0.066 0.03 DBMET00639 | DBMET00639 | |
| 0.02 | 0.313 | 0.121 | Cathepsin B inhibitor | 0.121 0.011 DBMET00706 | DBMET00706 | |
| 0.006 | 0.309 | 0.046 | Guanylate cyclase inhibitor | 0.039 0.034 DBMET00639 0.046 0.025 DBMET00706 | DBMET00706 | |
| 0.009 | 0.312 | 0.072 | Cathepsin L inhibitor | 0.072 0.028 DBMET00706 | DBMET00706 | |
| 0.014 | 0.318 | 0.056 | Cholesterol esterase inhibitor | 0.056 0.022 DBMET00706 | DBMET00706 | |
| 0.033 | 0.338 | 0.073 | GABA B receptor agonist | 0.073 0.06 DBMET00639 | DBMET00639 | |
| 0.079 | 0.384 | 0.378 | Transcription factor STAT inhibitor | 0.378 0.025 DBMET00639 | DBMET00639 | |
| 0.005 | 0.31 | 0.04 | Diamine oxidase inhibitor | 0.04 0.023 DBMET00706 | DBMET00706 | |
| 0.018 | 0.326 | 0.126 | NMDA receptor agonist | 0.126 0.012 DBMET00639 | DBMET00639 | |
| 0.057 | 0.364 | 0.227 | GABA C receptor rho-2 antagonist | 0.227 0.017 DBMET00639 0.169 0.052 DBMET00706 | DBMET00639 | |
| 0.01 | 0.318 | 0.211 | Acyl-CoA dehydrogenase inhibitor | 0.211 0.005 DBMET00639 0.061 0.032 DBMET00706 | DBMET00639 | |
| 0.02 | 0.332 | 0.147 | GABA aminotransferase inhibitor | 0.147 0.008 DBMET00639 | DBMET00639 | |
| 0.004 | 0.316 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.028 0.007 DBMET00639 | DBMET00639 | |
| 0.014 | 0.33 | 0.126 | Aconitate hydratase inhibitor | 0.126 0.005 DBMET00639 | DBMET00639 | |
| 0.094 | 0.411 | 0.196 | Ca2+-transporting ATPase inhibitor | 0.196 0.004 DBMET00639 0.146 0.054 DBMET00706 | DBMET00639 | |
| 0.029 | 0.346 | 0.148 | Anabolic | 0.148 0.019 DBMET00639 | DBMET00639 | |
| 0.013 | 0.331 | 0.292 | Monophenol monooxygenase inhibitor | 0.292 0.019 DBMET00639 | DBMET00639 | |
| 0.027 | 0.346 | 0.121 | Carbonic anhydrase VI inhibitor | 0.121 0.029 DBMET00639 | DBMET00639 | |
| 0.035 | 0.355 | 0.109 | NADH dehydrogenase inhibitor | 0.105 0.039 DBMET00639 0.109 0.036 DBMET00706 | DBMET00706 | |
| 0.01 | 0.329 | 0.035 | DNA-dependent protein kinase inhibitor | 0.035 0.034 DBMET00706 | DBMET00706 | |
| 0.007 | 0.33 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.014 DBMET00639 | DBMET00639 | |
| 0.008 | 0.331 | 0.14 | Toll-Like receptor 2 agonist | 0.14 0.012 DBMET00639 | DBMET00639 | |
| 0.072 | 0.396 | 0.24 | Superoxide dismutase inhibitor | 0.24 0.081 DBMET00639 | DBMET00639 | |
| 0.02 | 0.349 | 0.066 | Glutamate (mGluR7) antagonist | 0.066 0.051 DBMET00639 0.064 0.055 DBMET00706 | DBMET00639 | |
| 0.044 | 0.376 | 0.145 | Estrogen-related receptor beta agonist | 0.145 0.004 DBMET00639 | DBMET00639 | |
| 0.029 | 0.363 | 0.094 | Glutamate (mGluR6) antagonist | 0.094 0.013 DBMET00639 0.076 0.029 DBMET00706 | DBMET00639 | |
| 0.021 | 0.357 | 0.106 | Potassium channel (Ca-activated) activator | 0.106 0.051 DBMET00639 | DBMET00639 | |
| 0.027 | 0.371 | 0.096 | Uric acid excretion stimulant | 0.096 0.057 DBMET00639 | DBMET00639 | |
| 0.045 | 0.389 | 0.127 | Interleukin 12 antagonist | 0.127 0.023 DBMET00639 | DBMET00639 | |
| 0.001 | 0.346 | 0.042 | Prostaglandin EP4 agonist | 0.042 0.005 DBMET00639 | DBMET00639 | |
| 0.004 | 0.349 | 0.018 | Estrogen-related receptor gamma agonist | 0.018 0.014 DBMET00639 | DBMET00639 | |
| 0.078 | 0.424 | 0.264 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.203 0.07 DBMET00639 0.264 0.036 DBMET00706 | DBMET00706 | |
| 0.009 | 0.356 | 0.076 | Acetylcholine M5 receptor agonist | 0.076 0.038 DBMET00706 | DBMET00706 | |
| 0.024 | 0.374 | 0.098 | Aminopeptidase B inhibitor | 0.098 0.067 DBMET00639 | DBMET00639 | |
| 0.025 | 0.378 | 0.2 | Ferrochelatase inhibitor | 0.2 0.022 DBMET00639 0.136 0.044 DBMET00706 | DBMET00639 | |
| 0.018 | 0.373 | 0.129 | Carbonic anhydrase XIII inhibitor | 0.129 0.027 DBMET00639 | DBMET00639 | |
| 0.039 | 0.397 | 0.259 | Arachidonic acid antagonist | 0.259 0.004 DBMET00639 0.134 0.107 DBMET00706 | DBMET00639 | |
| 0.031 | 0.394 | 0.096 | Vanilloid 4 agonist | 0.096 0.02 DBMET00639 0.07 0.065 DBMET00706 | DBMET00639 | |
| 0.039 | 0.407 | 0.411 | Spasmolytic | 0.411 0.038 DBMET00639 0.188 0.13 DBMET00706 | DBMET00639 | |
| 0.034 | 0.403 | 0.261 | Toll-Like receptor 2 antagonist | 0.261 0.008 DBMET00639 | DBMET00639 | |
| 0.145 | 0.516 | 0.406 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.309 0.201 DBMET00639 0.406 0.095 DBMET00706 | DBMET00706 | |
| 0.027 | 0.4 | 0.057 | Kallikrein 1 inhibitor | 0.057 0.037 DBMET00706 | DBMET00706 | |
| 0.002 | 0.377 | 0.049 | Prostaglandin EP2 agonist | 0.049 0.006 DBMET00639 | DBMET00639 | |
| 0.081 | 0.455 | 0.287 | Insulysin inhibitor | 0.287 0.067 DBMET00639 0.187 0.178 DBMET00706 | DBMET00639 | |
| 0.012 | 0.388 | 0.125 | Histidine decarboxylase inhibitor | 0.125 0.024 DBMET00639 | DBMET00639 | |
| 0.01 | 0.39 | 0.035 | Melatonin receptor 1A agonist | 0.035 0.019 DBMET00639 | DBMET00639 | |
| 0.019 | 0.402 | 0.091 | Falcipain 3 inhibitor | 0.091 0.08 DBMET00639 | DBMET00639 | |
| 0.008 | 0.393 | 0.062 | Carbonic anhydrase XIV inhibitor | 0.062 0.024 DBMET00639 | DBMET00639 | |
| 0.073 | 0.457 | 0.158 | Neurotensin receptor agonist | 0.158 0.082 DBMET00639 | DBMET00639 | |
| 0.005 | 0.39 | 0.072 | Prostaglandin F2 alpha agonist | 0.072 0.003 DBMET00639 | DBMET00639 | |
| 0.026 | 0.412 | 0.161 | GABA C receptor rho-1 antagonist | 0.161 0.017 DBMET00639 0.111 0.049 DBMET00706 | DBMET00639 | |
| 0.005 | 0.397 | 0.038 | Epoxide hydrolase 1 inhibitor | 0.038 0.012 DBMET00639 | DBMET00639 | |
| 0.024 | 0.42 | 0.181 | Glycine receptor agonist | 0.181 0.005 DBMET00639 0.073 0.049 DBMET00706 | DBMET00639 | |
| 0.031 | 0.429 | 0.092 | mTOR complex 2 inhibitor | 0.083 0.062 DBMET00639 0.092 0.043 DBMET00706 | DBMET00706 | |
| 0.022 | 0.427 | 0.103 | 5 Hydroxytryptamine 3A agonist | 0.103 0.072 DBMET00706 | DBMET00706 | |
| 0.011 | 0.416 | 0.064 | Neuraminidase (influenza) inhibitor | 0.064 0.044 DBMET00639 | DBMET00639 | |
| 0.014 | 0.421 | 0.079 | Aminopeptidase I inhibitor | 0.079 0.043 DBMET00639 | DBMET00639 | |
| 0.004 | 0.411 | 0.037 | Cathepsin L1 inhibitor | 0.037 0.03 DBMET00706 | DBMET00706 | |
| 0.006 | 0.414 | 0.044 | GABA uptake inhibitor | 0.044 0.021 DBMET00639 | DBMET00639 | |
| 0.011 | 0.42 | 0.045 | AICAR transformylase inhibitor | 0.045 0.029 DBMET00639 | DBMET00639 | |
| 0.027 | 0.435 | 0.125 | Xanthine oxidase inhibitor | 0.125 0.045 DBMET00639 | DBMET00639 | |
| 0.01 | 0.419 | 0.246 | Catalase inhibitor | 0.246 0.009 DBMET00639 | DBMET00639 | |
| 0.022 | 0.434 | 0.124 | Glutathione S-transferase inhibitor | 0.124 0.02 DBMET00639 | DBMET00639 | |
| 0.046 | 0.46 | 0.315 | Melanin inhibitor | 0.315 0.02 DBMET00639 | DBMET00639 | |
| 0.02 | 0.437 | 0.165 | GABA C receptor antagonist | 0.165 0.023 DBMET00639 0.132 0.042 DBMET00706 | DBMET00639 | |
| 0.03 | 0.452 | 0.138 | Interleukin 1b antagonist | 0.138 0.049 DBMET00639 | DBMET00639 | |
| 0.042 | 0.468 | 0.126 | Pregnane X receptor agonist | 0.126 0.111 DBMET00639 | DBMET00639 | |
| 0.012 | 0.438 | 0.06 | Squalene epoxidase inhibitor | 0.06 0.02 DBMET00639 | DBMET00639 | |
| 0.026 | 0.457 | 0.102 | Bile acid receptor antagonist | 0.102 0.045 DBMET00639 | DBMET00639 | |
| 0.02 | 0.451 | 0.249 | Microtubule formation inhibitor | 0.249 0.009 DBMET00639 0.102 0.088 DBMET00706 | DBMET00639 | |
| 0.004 | 0.436 | 0.08 | Oleamide hydrolase inhibitor | 0.08 0.013 DBMET00639 | DBMET00639 | |
| 0.014 | 0.449 | 0.216 | Calcium antagonist | 0.216 0.012 DBMET00639 | DBMET00639 | |
| 0.007 | 0.444 | 0.056 | Factor XIIIa inhibitor | 0.056 0.013 DBMET00639 | DBMET00639 | |
| 0.008 | 0.445 | 0.032 | Glutamate (mGluR3) agonist | 0.032 0.023 DBMET00639 | DBMET00639 | |
| 0.013 | 0.449 | 0.054 | Dopamine beta hydroxylase inhibitor | 0.054 0.023 DBMET00639 | DBMET00639 | |
| 0.017 | 0.454 | 0.056 | Nicotinic alpha3beta2 receptor antagonist | 0.056 0.032 DBMET00639 | DBMET00639 | |
| 0.015 | 0.454 | 0.104 | Glycine receptor antagonist | 0.104 0.029 DBMET00639 | DBMET00639 | |
| 0.018 | 0.458 | 0.287 | Cystathionine beta-synthase inhibitor | 0.287 0.011 DBMET00639 0.093 0.085 DBMET00706 | DBMET00639 | |
| 0.003 | 0.443 | 0.06 | Retinoid X receptor agonist | 0.06 0.014 DBMET00639 | DBMET00639 | |
| 0.029 | 0.47 | 0.149 | Acetylcholine release stimulant | 0.149 0.017 DBMET00639 | DBMET00639 | |
| 0.017 | 0.458 | 0.06 | Dihydroorotate oxidase inhibitor | 0.06 0.028 DBMET00639 | DBMET00639 | |
| 0.03 | 0.472 | 0.168 | Lanosterol 14 alpha demethylase inhibitor | 0.168 0.007 DBMET00639 | DBMET00639 | |
| 0.002 | 0.447 | 0.036 | Prostaglandin H2 antagonist | 0.036 0.008 DBMET00639 | DBMET00639 | |
| 0.005 | 0.451 | 0.023 | Neuraminidase (Influenza B) inhibitor | 0.023 0.01 DBMET00639 | DBMET00639 | |
| 0.075 | 0.524 | 0.32 | Calcium channel activator | 0.32 0.073 DBMET00639 | DBMET00639 | |
| 0.015 | 0.467 | 0.089 | Potassium channel (Tandem pore domain) blocker | 0.089 0.018 DBMET00639 0.073 0.055 DBMET00706 | DBMET00639 | |
| 0.003 | 0.455 | 0.043 | Kainate receptor 2 antagonist | 0.043 0.02 DBMET00639 | DBMET00639 | |
| 0.093 | 0.546 | 0.357 | 5 Hydroxytryptamine release inhibitor | 0.357 0.109 DBMET00639 0.35 0.116 DBMET00706 | DBMET00639 | |
| 0.097 | 0.55 | 0.774 | Caspase 9 stimulant | 0.774 0.015 DBMET00639 | DBMET00639 | |
| 0.028 | 0.481 | 0.432 | Immunostimulant | 0.432 0.041 DBMET00639 | DBMET00639 | |
| 0.028 | 0.482 | 0.145 | Granulocyte macrophage colony stimulating factor agonist | 0.145 0.006 DBMET00639 | DBMET00639 | |
| 0.018 | 0.473 | 0.06 | CD45 antagonist | 0.06 0.021 DBMET00639 | DBMET00639 | |
| 0.01 | 0.467 | 0.048 | Adenylate cyclase 1 inhibitor | 0.048 0.029 DBMET00639 | DBMET00639 | |
| 0.064 | 0.521 | 0.331 | Vasodilator, coronary | 0.331 0.066 DBMET00639 | DBMET00639 | |
| 0.002 | 0.464 | 0.054 | Prostaglandin E2 agonist | 0.054 0.005 DBMET00639 | DBMET00639 | |
| 0.019 | 0.484 | 0.182 | Prolactin inhibitor | 0.182 0.012 DBMET00639 | DBMET00639 | |
| 0.003 | 0.472 | 0.122 | Prostaglandin agonist | 0.122 0.004 DBMET00639 | DBMET00639 | |
| 0.032 | 0.501 | 0.149 | Peroxidase inhibitor | 0.149 0.078 DBMET00639 0.141 0.083 DBMET00706 | DBMET00639 | |
| 0.005 | 0.475 | 0.037 | CDK5/p25 inhibitor | 0.037 0.033 DBMET00706 | DBMET00706 | |
| 0.003 | 0.479 | 0.027 | Cyclin E2 inhibitor | 0.027 0.022 DBMET00706 | DBMET00706 | |
| 0.004 | 0.481 | 0.025 | Retinoid X beta receptor antagonist | 0.025 0.007 DBMET00639 | DBMET00639 | |
| 0.011 | 0.489 | 0.049 | Cytokine production stimulant | 0.049 0.032 DBMET00639 0.045 0.044 DBMET00706 | DBMET00639 | |
| 0.015 | 0.496 | 0.09 | DNA intercalator | 0.09 0.086 DBMET00706 | DBMET00706 | |
| 0.03 | 0.512 | 0.133 | Sphingosine 1-phosphate receptor 2 antagonist | 0.133 0.068 DBMET00639 | DBMET00639 | |
| 0.059 | 0.547 | 0.371 | RNA-directed DNA polymerase inhibitor | 0.371 0.021 DBMET00639 0.178 0.136 DBMET00706 | DBMET00639 | |
| 0.043 | 0.535 | 0.128 | CF transmembrane conductance regulator agonist | 0.128 0.123 DBMET00639 | DBMET00639 | |
| 0.002 | 0.495 | 0.028 | Vitamin D receptor agonist | 0.028 0.004 DBMET00639 | DBMET00639 | |
| 0.036 | 0.531 | 0.215 | Adenylate cyclase stimulant | 0.215 0.008 DBMET00639 0.138 0.085 DBMET00706 | DBMET00639 | |
| 0.022 | 0.517 | 0.083 | HIV-1 integrase (Overall Integration) inhibitor | 0.083 0.074 DBMET00639 | DBMET00639 | |
| 0.003 | 0.501 | 0.064 | Methionyl aminopeptidase 1 inhibitor | 0.064 0.005 DBMET00639 | DBMET00639 | |
| 0.004 | 0.504 | 0.059 | Potassium channel Kv1.3 blocker | 0.059 0.022 DBMET00639 | DBMET00639 | |
| 0.015 | 0.516 | 0.149 | Ornithine decarboxylase inhibitor | 0.149 0.011 DBMET00639 | DBMET00639 | |
| 0.04 | 0.544 | 0.315 | 15-Lipoxygenase inhibitor | 0.315 0.122 DBMET00639 | DBMET00639 | |
| 0.003 | 0.512 | 0.044 | Kainate receptor antagonist | 0.044 0.025 DBMET00639 | DBMET00639 | |
| 0.006 | 0.516 | 0.099 | Amidase inhibitor | 0.099 0.025 DBMET00639 | DBMET00639 | |
| 0.005 | 0.515 | 0.046 | Cyclin E1 inhibitor | 0.046 0.039 DBMET00706 | DBMET00706 | |
| 0.061 | 0.58 | 0.39 | 5 Hydroxytryptamine release stimulant | 0.39 0.048 DBMET00639 0.246 0.091 DBMET00706 | DBMET00639 | |
| 0.004 | 0.524 | 0.045 | Retinoid X alpha receptor agonist | 0.045 0.016 DBMET00639 | DBMET00639 | |
| 0.02 | 0.543 | 0.108 | Calcium channel blocker | 0.108 0.103 DBMET00639 | DBMET00639 | |
| 0.008 | 0.533 | 0.083 | Sphingosine 1-phosphate receptor 4 agonist | 0.083 0.034 DBMET00639 | DBMET00639 | |
| 0.006 | 0.534 | 0.05 | Prolyl endopeptidase inhibitor | 0.05 0.036 DBMET00639 | DBMET00639 | |
| 0.008 | 0.539 | 0.155 | Anesthetic local | 0.155 0.047 DBMET00639 | DBMET00639 | |
| 0.018 | 0.549 | 0.13 | Sphingomyelinase inhibitor | 0.13 0.035 DBMET00639 | DBMET00639 | |
| 0.007 | 0.538 | 0.091 | Membrane dipeptidase inhibitor | 0.091 0.004 DBMET00639 | DBMET00639 | |
| 0.012 | 0.547 | 0.085 | Fatty acid synthase inhibitor | 0.085 0.016 DBMET00639 | DBMET00639 | |
| 0.012 | 0.548 | 0.206 | Mucolytic | 0.206 0.012 DBMET00639 | DBMET00639 | |
| 0.012 | 0.548 | 0.182 | Cholesterol synthesis inhibitor | 0.182 0.032 DBMET00639 | DBMET00639 | |
| 0.003 | 0.54 | 0.026 | Nicotinic acid receptor 2 antagonist | 0.026 0.019 DBMET00639 | DBMET00639 | |
| 0.086 | 0.623 | 0.344 | 5 Hydroxytryptamine uptake stimulant | 0.344 0.027 DBMET00639 0.225 0.111 DBMET00706 | DBMET00639 | |
| 0.014 | 0.552 | 0.082 | Myeloperoxidase inhibitor | 0.082 0.063 DBMET00706 | DBMET00706 | |
| 0.035 | 0.575 | 0.349 | Interferon gamma antagonist | 0.349 0.014 DBMET00639 | DBMET00639 | |
| 0.024 | 0.563 | 0.297 | TRPA1 agonist | 0.297 0.005 DBMET00639 | DBMET00639 | |
| 0.026 | 0.568 | 0.178 | Cyclooxygenase 3 inhibitor | 0.178 0.029 DBMET00639 | DBMET00639 | |
| 0.097 | 0.638 | 0.367 | Calcium channel L-type activator | 0.367 0.105 DBMET00639 | DBMET00639 | |
| 0.005 | 0.547 | 0.073 | Glycine transporter 2 inhibitor | 0.073 0.019 DBMET00639 | DBMET00639 | |
| 0.026 | 0.569 | 0.398 | Lipoxygenase inhibitor | 0.398 0.038 DBMET00639 | DBMET00639 | |
| 0.018 | 0.563 | 0.156 | Proteasome inhibitor | 0.156 0.043 DBMET00639 | DBMET00639 | |
| 0.011 | 0.556 | 0.082 | Pregnane X receptor antagonist | 0.082 0.005 DBMET00639 | DBMET00639 | |
| 0.005 | 0.55 | 0.064 | Neuraminidase inhibitor | 0.064 0.039 DBMET00639 | DBMET00639 | |
| 0.004 | 0.552 | 0.101 | Thromboxane antagonist | 0.101 0.011 DBMET00639 | DBMET00639 | |
| 0.003 | 0.55 | 0.054 | Antimetabolite | 0.054 0.029 DBMET00639 | DBMET00639 | |
| 0.014 | 0.565 | 0.343 | Phospholipase A2 inhibitor | 0.343 0.008 DBMET00639 | DBMET00639 | |
| 0.006 | 0.558 | 0.05 | HCV NS3/NS4A protease inhibitor | 0.05 0.032 DBMET00639 0.045 0.042 DBMET00706 | DBMET00639 | |
| 0.028 | 0.581 | 0.095 | Glutamate (mGluR7) agonist | 0.095 0.07 DBMET00639 0.089 0.086 DBMET00706 | DBMET00639 | |
| 0.011 | 0.571 | 0.086 | Phospholipase D inhibitor | 0.086 0.026 DBMET00639 | DBMET00639 | |
| 0.014 | 0.578 | 0.154 | Caspase 3 inhibitor | 0.154 0.025 DBMET00639 | DBMET00639 | |
| 0.003 | 0.569 | 0.029 | Lysophosphatidic acid 1 receptor antagonist | 0.029 0.007 DBMET00639 | DBMET00639 | |
| 0.033 | 0.6 | 0.181 | Histone acetyltransferase inhibitor | 0.181 0.098 DBMET00639 | DBMET00639 | |
| 0.006 | 0.574 | 0.087 | Thromboxane synthase inhibitor | 0.087 0.009 DBMET00639 | DBMET00639 | |
| 0.042 | 0.61 | 0.402 | Histamine release inhibitor | 0.402 0.075 DBMET00639 | DBMET00639 | |
| 0.004 | 0.573 | 0.062 | Cyclin E inhibitor | 0.062 0.04 DBMET00706 | DBMET00706 | |
| 0.032 | 0.602 | 0.369 | Phospholipase C inhibitor | 0.369 0.013 DBMET00639 | DBMET00639 | |
| 0.008 | 0.579 | 0.043 | Retinoid X alpha receptor antagonist | 0.043 0.012 DBMET00639 | DBMET00639 | |
| 0.024 | 0.603 | 0.247 | Photosensitizer | 0.247 0.006 DBMET00639 | DBMET00639 | |
| 0.034 | 0.613 | 0.299 | Vanilloid 1 agonist | 0.299 0.004 DBMET00639 | DBMET00639 | |
| 0.005 | 0.585 | 0.049 | Leukotriene C4 antagonist | 0.049 0.011 DBMET00639 | DBMET00639 | |
| 0.008 | 0.589 | 0.051 | Retinoid X receptor antagonist | 0.051 0.012 DBMET00639 | DBMET00639 | |
| 0.011 | 0.593 | 0.099 | Cathepsin G inhibitor | 0.099 0.034 DBMET00639 | DBMET00639 | |
| 0.015 | 0.601 | 0.114 | Keratolytic | 0.114 0.024 DBMET00639 | DBMET00639 | |
| 0.007 | 0.598 | 0.027 | Glucosylceramidase stimulant | 0.027 0.021 DBMET00639 | DBMET00639 | |
| 0.033 | 0.625 | 0.192 | Neuropeptide Y2 antagonist | 0.192 0.134 DBMET00706 | DBMET00706 | |
| 0.032 | 0.625 | 0.228 | Neurotrophic factor enhancer | 0.228 0.053 DBMET00639 | DBMET00639 | |
| 0.003 | 0.598 | 0.099 | Peroxisome proliferator-activated receptor alpha agonist | 0.099 0.013 DBMET00639 | DBMET00639 | |
| 0.003 | 0.599 | 0.038 | Inosine monophosphate dehydrogenase inhibitor | 0.038 0.023 DBMET00639 | DBMET00639 | |
| 0.009 | 0.606 | 0.454 | Anesthetic general | 0.454 0.011 DBMET00639 0.154 0.11 DBMET00706 | DBMET00639 | |
| 0.004 | 0.601 | 0.071 | Leukocyte elastase inhibitor | 0.071 0.014 DBMET00639 | DBMET00639 | |
| 0.005 | 0.604 | 0.085 | Nicotinic alpha4beta2 receptor antagonist | 0.085 0.045 DBMET00639 | DBMET00639 | |
| 0.022 | 0.622 | 0.247 | Interleukin 1 antagonist | 0.247 0.019 DBMET00639 | DBMET00639 | |
| 0.007 | 0.609 | 0.073 | Leukotriene C antagonist | 0.073 0.011 DBMET00639 | DBMET00639 | |
| 0.008 | 0.611 | 0.249 | Expectorant | 0.249 0.013 DBMET00639 | DBMET00639 | |
| 0.003 | 0.611 | 0.093 | Thromboxane A2 antagonist | 0.093 0.009 DBMET00639 | DBMET00639 | |
| 0.018 | 0.628 | 0.22 | Thioredoxin inhibitor | 0.22 0.006 DBMET00639 0.081 0.079 DBMET00706 | DBMET00639 | |
| 0.01 | 0.624 | 0.1 | Interferon inducer | 0.1 0.012 DBMET00639 | DBMET00639 | |
| 0.028 | 0.642 | 0.138 | Sphingosine 1-phosphate receptor 5 antagonist | 0.138 0.084 DBMET00639 | DBMET00639 | |
| 0.004 | 0.618 | 0.078 | Leukotriene B4 antagonist | 0.078 0.016 DBMET00639 | DBMET00639 | |
| 0.003 | 0.618 | 0.035 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.035 0.023 DBMET00639 | DBMET00639 | |
| 0.017 | 0.631 | 0.12 | Electrolyte absorption antagonist | 0.12 0.036 DBMET00639 | DBMET00639 | |
| 0.007 | 0.622 | 0.064 | Adenosine deaminase inhibitor | 0.064 0.017 DBMET00639 | DBMET00639 | |
| 0.02 | 0.635 | 0.135 | Neuropeptide Y1 antagonist | 0.135 0.091 DBMET00639 | DBMET00639 | |
| 0.005 | 0.623 | 0.099 | Inducible nitric-oxide synthase inhibitor | 0.099 0.038 DBMET00639 0.082 0.059 DBMET00706 | DBMET00639 | |
| 0.004 | 0.628 | 0.079 | Epoxide hydrolase inhibitor | 0.079 0.043 DBMET00639 | DBMET00639 | |
| 0.009 | 0.634 | 0.071 | Calcium channel L-type blocker | 0.071 0.051 DBMET00639 | DBMET00639 | |
| 0.028 | 0.656 | 0.423 | Interleukin agonist | 0.423 0.016 DBMET00639 | DBMET00639 | |
| 0.005 | 0.633 | 0.049 | Benzodiazepine antagonist | 0.049 0.03 DBMET00639 | DBMET00639 | |
| 0.02 | 0.65 | 0.253 | Aldehyde oxidase inhibitor | 0.253 0.081 DBMET00639 0.165 0.127 DBMET00706 | DBMET00639 | |
| 0.018 | 0.649 | 0.452 | Antioxidant | 0.452 0.026 DBMET00639 | DBMET00639 | |
| 0.004 | 0.636 | 0.08 | 5 Hydroxytryptamine 3A antagonist | 0.08 0.031 DBMET00706 | DBMET00706 | |
| 0.004 | 0.637 | 0.04 | Dihydrofolate reductase inhibitor | 0.04 0.038 DBMET00639 | DBMET00639 | |
| 0.015 | 0.652 | 0.509 | Protein kinase stimulant | 0.509 0.004 DBMET00639 | DBMET00639 | |
| 0.023 | 0.66 | 0.26 | Cyclic AMP phosphodiesterase inhibitor | 0.26 0.059 DBMET00639 | DBMET00639 | |
| 0.008 | 0.659 | 0.207 | Interferon agonist | 0.207 0.005 DBMET00639 | DBMET00639 | |
| 0.036 | 0.688 | 0.641 | Vasodilator, peripheral | 0.641 0.011 DBMET00639 | DBMET00639 | |
| 0.033 | 0.687 | 0.147 | Glutamate release inhibitor | 0.147 0.01 DBMET00639 | DBMET00639 | |
| 0.029 | 0.69 | 0.361 | Gastrin inhibitor | 0.361 0.008 DBMET00639 | DBMET00639 | |
| 0.006 | 0.67 | 0.247 | Psychostimulant | 0.247 0.059 DBMET00639 | DBMET00639 | |
| 0.004 | 0.669 | 0.036 | Nicotinic acid receptor agonist | 0.036 0.025 DBMET00639 | DBMET00639 | |
| 0.002 | 0.667 | 0.046 | 5-Alpha-reductase inhibitor | 0.046 0.02 DBMET00639 | DBMET00639 | |
| 0.006 | 0.677 | 0.06 | DNA gyrase inhibitor | 0.06 0.048 DBMET00706 | DBMET00706 | |
| 0.007 | 0.689 | 0.053 | Glucosylceramidase inhibitor | 0.053 0.041 DBMET00706 | DBMET00706 | |
| 0.008 | 0.691 | 0.045 | Vanilloid 3 antagonist | 0.045 0.013 DBMET00639 | DBMET00639 | |
| 0.004 | 0.69 | 0.029 | Glutamate (mGluR2) agonist | 0.029 0.026 DBMET00706 | DBMET00706 | |
| 0.024 | 0.715 | 0.145 | Hexokinase inhibitor | 0.145 0.085 DBMET00639 | DBMET00639 | |
| 0.002 | 0.694 | 0.036 | Farnesoid X receptor agonist | 0.036 0.029 DBMET00639 | DBMET00639 | |
| 0.003 | 0.698 | 0.078 | Cannabinoid CB2 receptor antagonist | 0.078 0.02 DBMET00639 | DBMET00639 | |
| 0.003 | 0.699 | 0.029 | Elastase 2A inhibitor | 0.029 0.01 DBMET00639 | DBMET00639 | |
| 0.003 | 0.699 | 0.029 | Elastase 2 inhibitor | 0.029 0.01 DBMET00639 | DBMET00639 | |
| 0.006 | 0.701 | 0.092 | Peroxisome proliferator-activated receptor gamma antagonist | 0.092 0.021 DBMET00639 | DBMET00639 | |
| 0.009 | 0.708 | 0.103 | DNA gyrase subunit A inhibitor | 0.103 0.004 DBMET00706 | DBMET00706 | |
| 0.004 | 0.708 | 0.419 | Cyclin-dependent kinase 5 inhibitor | 0.419 0.005 DBMET00706 | DBMET00706 | |
| 0.005 | 0.709 | 0.032 | Glutamate (mGluR group II) agonist | 0.032 0.027 DBMET00706 | DBMET00706 | |
| 0.008 | 0.718 | 0.146 | Mediator release inhibitor | 0.146 0.03 DBMET00639 | DBMET00639 | |
| 0.002 | 0.714 | 0.044 | Geranyltranstransferase inhibitor | 0.044 0.031 DBMET00639 | DBMET00639 | |
| 0.007 | 0.721 | 0.093 | GABA receptor agonist | 0.093 0.085 DBMET00639 | DBMET00639 | |
| 0.003 | 0.718 | 0.083 | Lysophosphatidic acid 2 receptor antagonist | 0.083 0.005 DBMET00639 | DBMET00639 | |
| 0.013 | 0.732 | 0.579 | Transcription factor NF kappa B inhibitor | 0.579 0.034 DBMET00639 | DBMET00639 | |
| 0.01 | 0.729 | 0.049 | Autotaxin inhibitor | 0.049 0.042 DBMET00639 | DBMET00639 | |
| 0.02 | 0.743 | 0.649 | Cholesterol antagonist | 0.649 0.013 DBMET00639 | DBMET00639 | |
| 0.005 | 0.733 | 0.12 | Nitric-oxide synthase inhibitor | 0.12 0.038 DBMET00639 0.091 0.075 DBMET00706 | DBMET00639 | |
| 0.008 | 0.737 | 0.113 | Topoisomerase II alpha inhibitor | 0.113 0.032 DBMET00639 | DBMET00639 | |
| 0.017 | 0.753 | 0.059 | Caspase 9 inhibitor | 0.059 0.048 DBMET00639 | DBMET00639 | |
| 0.003 | 0.744 | 0.11 | Leukotriene antagonist | 0.11 0.018 DBMET00639 | DBMET00639 | |
| 0.049 | 0.791 | 0.148 | Heat shock protein 70 antagonist | 0.148 0.051 DBMET00639 | DBMET00639 | |
| 0.008 | 0.75 | 0.366 | Insulin sensitizer | 0.366 0.008 DBMET00639 | DBMET00639 | |
| 0.025 | 0.769 | 0.687 | Apoptosis agonist | 0.687 0.033 DBMET00639 | DBMET00639 | |
| 0.007 | 0.756 | 0.029 | DNA topoisomerase IV inhibitor | 0.029 0.023 DBMET00706 | DBMET00706 | |
| 0.01 | 0.764 | 0.068 | Phosphodiesterase VI inhibitor | 0.068 0.067 DBMET00639 | DBMET00639 | |
| 0.013 | 0.772 | 0.536 | Antithrombotic | 0.536 0.024 DBMET00639 | DBMET00639 | |
| 0.014 | 0.774 | 0.134 | Cytokine production inhibitor | 0.134 0.076 DBMET00639 | DBMET00639 | |
| 0.006 | 0.772 | 0.1 | Interleukin 1 beta converting enzyme inhibitor | 0.1 0.057 DBMET00639 | DBMET00639 | |
| 0.007 | 0.778 | 0.059 | Elastase 3A inhibitor | 0.059 0.004 DBMET00639 | DBMET00639 | |
| 0.007 | 0.778 | 0.059 | Elastase 3B inhibitor | 0.059 0.004 DBMET00639 | DBMET00639 | |
| 0.007 | 0.778 | 0.059 | Elastase 2B inhibitor | 0.059 0.004 DBMET00639 | DBMET00639 | |
| 0.002 | 0.776 | 0.058 | Prostaglandin EP4 antagonist | 0.058 0.007 DBMET00639 | DBMET00639 | |
| 0.01 | 0.786 | 0.454 | Nitric oxide antagonist | 0.454 0.02 DBMET00639 | DBMET00639 | |
| 0.004 | 0.781 | 0.052 | Microtubule stabilization | 0.052 0.026 DBMET00639 | DBMET00639 | |
| 0.004 | 0.783 | 0.227 | Protein-tyrosine phosphatase 1B inhibitor | 0.227 0.022 DBMET00639 | DBMET00639 | |
| 0.049 | 0.828 | 0.567 | Interleukin 2 agonist | 0.567 0.004 DBMET00639 | DBMET00639 | |
| 0.014 | 0.796 | 0.113 | Phosphodiesterase 6D inhibitor | 0.113 0.033 DBMET00639 | DBMET00639 | |
| 0.005 | 0.788 | 0.105 | Cyclin-dependent kinase inhibitor | 0.105 0.086 DBMET00706 | DBMET00706 | |
| 0.015 | 0.801 | 0.219 | Toll-Like receptor 4 antagonist | 0.219 0.005 DBMET00639 | DBMET00639 | |
| 0.01 | 0.811 | 0.051 | Calcium-independent phospholipase A2 inhibitor | 0.051 0.004 DBMET00639 | DBMET00639 | |
| 0.012 | 0.814 | 0.153 | Farnesoid X receptor antagonist | 0.153 0.049 DBMET00639 | DBMET00639 | |
| 0.012 | 0.818 | 0.085 | Vanilloid 2 antagonist | 0.085 0.008 DBMET00639 | DBMET00639 | |
| 0.009 | 0.823 | 0.152 | Interleukin 8 antagonist | 0.152 0.033 DBMET00639 | DBMET00639 | |
| 0.005 | 0.822 | 0.283 | Maillard reaction inhibitor | 0.055 0.038 DBMET00639 0.283 0.003 DBMET00706 | DBMET00706 | |
| 0.001 | 0.821 | 0.045 | Immunosuppressant Cyclosporine-like | 0.045 0.001 DBMET00639 | DBMET00639 | |
| 0.002 | 0.824 | 0.071 | TRPA1 antagonist | 0.071 0.032 DBMET00639 | DBMET00639 | |
| 0.032 | 0.856 | 0.156 | Lipocortins synthesis antagonist | 0.156 0.097 DBMET00639 | DBMET00639 | |
| 0.005 | 0.83 | 0.265 | Protein-tyrosine phosphatase inhibitor | 0.265 0.027 DBMET00639 | DBMET00639 | |
| 0.005 | 0.841 | 0.44 | Non-steroidal antiinflammatory agent | 0.44 0.01 DBMET00639 | DBMET00639 | |
| 0.004 | 0.841 | 0.147 | Lipase inhibitor | 0.09 0.034 DBMET00639 0.147 0.01 DBMET00706 | DBMET00706 | |
| 0.004 | 0.845 | 0.126 | Beta amyloid protein antagonist | 0.126 0.061 DBMET00639 | DBMET00639 | |
| 0.001 | 0.847 | 0.014 | Calcium-dependent phospholipase A2 inhibitor | 0.014 0.007 DBMET00639 | DBMET00639 | |
| 0.004 | 0.85 | 0.259 | Gastric antisecretory | 0.259 0.006 DBMET00639 | DBMET00639 | |
| 0.005 | 0.854 | 0.144 | Tubulin antagonist | 0.144 0.06 DBMET00639 | DBMET00639 | |
| 0.001 | 0.852 | 0.027 | Calcineurin inhibitor | 0.027 0.002 DBMET00639 | DBMET00639 | |
| 0.009 | 0.866 | 0.365 | Interleukin 6 antagonist | 0.365 0.009 DBMET00639 | DBMET00639 | |
| 0.004 | 0.861 | 0.111 | Prostaglandin antagonist | 0.111 0.015 DBMET00639 | DBMET00639 | |
| 0.012 | 0.879 | 0.292 | Tumour necrosis factor antagonist | 0.292 0.02 DBMET00639 | DBMET00639 | |
| 0.016 | 0.889 | 0.074 | Lipocortins synthesis agonist | 0.074 0.018 DBMET00639 | DBMET00639 | |
| 0.005 | 0.878 | 0.152 | Antiamyloidogenic | 0.152 0.144 DBMET00639 | DBMET00639 | |
| 0.011 | 0.885 | 0.125 | Antineoplastic alkaloid | 0.125 0.036 DBMET00639 | DBMET00639 | |
| 0.008 | 0.886 | 0.41 | Angiogenesis stimulant | 0.41 0.02 DBMET00639 | DBMET00639 | |
| 0.015 | 0.902 | 0.384 | Hepatoprotectant | 0.384 0.015 DBMET00639 | DBMET00639 | |
| 0.007 | 0.896 | 0.248 | Hemostatic | 0.248 0.022 DBMET00639 | DBMET00639 | |
| 0.002 | 0.892 | 0.081 | Prostaglandin D2 agonist | 0.081 0.004 DBMET00639 | DBMET00639 | |
| 0.006 | 0.9 | 0.546 | P-glycoprotein inhibitor | 0.546 0.006 DBMET00639 | DBMET00639 | |
| 0.006 | 0.905 | 0.158 | ATPase (Vacuolar H+) inhibitor | 0.158 0.006 DBMET00639 | DBMET00639 | |
| 0.001 | 0.901 | 0.076 | Prostacyclin agonist | 0.076 0.004 DBMET00639 | DBMET00639 | |
| 0.022 | 0.922 | 0.44 | Sodium/bile acid cotransporter inhibitor | 0.44 0.009 DBMET00639 | DBMET00639 | |
| 0.002 | 0.903 | 0.202 | Antineoplastic antibiotic | 0.202 0.021 DBMET00639 | DBMET00639 | |
| 0.01 | 0.915 | 0.073 | ErbB-3 antagonist | 0.073 0.071 DBMET00639 | DBMET00639 | |
| 0.009 | 0.914 | 0.477 | Platelet adhesion inhibitor | 0.477 0.006 DBMET00639 | DBMET00639 | |
| 0.013 | 0.922 | 0.505 | Interleukin 4 antagonist | 0.505 0.004 DBMET00639 | DBMET00639 | |
| 0.003 | 0.915 | 0.17 | Prostaglandin EP2 antagonist | 0.17 0.008 DBMET00639 | DBMET00639 | |
| 0.004 | 0.922 | 0.079 | CDC25A inhibitor | 0.079 0.044 DBMET00639 | DBMET00639 | |
| 0.004 | 0.924 | 0.12 | Cyclooxygenase 1 inhibitor | 0.12 0.081 DBMET00639 | DBMET00639 | |
| 0.01 | 0.933 | 0.159 | Electron transport complex I inhibitor | 0.159 0.017 DBMET00639 | DBMET00639 | |
| 0.004 | 0.93 | 0.249 | Lipid peroxidase inhibitor | 0.249 0.027 DBMET00639 | DBMET00639 | |
| 0.003 | 0.931 | 0.182 | Diuretic | 0.182 0.053 DBMET00639 | DBMET00639 | |
| 0.006 | 0.94 | 0.113 | Elastase 1 inhibitor | 0.113 0.014 DBMET00639 | DBMET00639 | |
| 0.01 | 0.947 | 0.158 | Interleukin 5 antagonist | 0.158 0.009 DBMET00639 | DBMET00639 | |
| 0.004 | 0.943 | 0.198 | 5-Lipoxygenase inhibitor | 0.198 0.025 DBMET00639 | DBMET00639 | |
| 0.015 | 0.954 | 0.199 | Transcription factor NF kappa B stimulant | 0.199 0.009 DBMET00639 | DBMET00639 | |
| 0.019 | 0.959 | 0.242 | NOS3 expression enhancer | 0.242 0.028 DBMET00639 | DBMET00639 | |
| 0.02 | 0.961 | 0.133 | Growth hormone agonist | 0.133 0.103 DBMET00639 | DBMET00639 | |
| 0.005 | 0.947 | 0.104 | Multidrug resistance-associated protein 1 inhibitor | 0.104 0.072 DBMET00639 | DBMET00639 | |
| 0.006 | 0.95 | 0.482 | Hypoglycemic | 0.475 0.018 DBMET00639 0.482 0.017 DBMET00706 | DBMET00706 | |
| 0.005 | 0.949 | 0.427 | Interleukin antagonist | 0.427 0.027 DBMET00639 | DBMET00639 | |
| 0.002 | 0.948 | 0.041 | Prostaglandin EP3 antagonist | 0.041 0.013 DBMET00639 | DBMET00639 | |
| 0.004 | 0.951 | 0.143 | Cyclophilin A inhibitor | 0.143 0.003 DBMET00639 | DBMET00639 | |
| 0.004 | 0.952 | 0.24 | Antipruritic | 0.24 0.028 DBMET00639 | DBMET00639 | |
| 0.003 | 0.952 | 0.142 | Peroxisome proliferator-activated receptor gamma agonist | 0.142 0.014 DBMET00639 | DBMET00639 | |
| 0.003 | 0.953 | 0.092 | Selectin antagonist | 0.092 0.031 DBMET00639 | DBMET00639 | |
| 0.004 | 0.964 | 0.161 | Antimitotic | 0.161 0.111 DBMET00639 | DBMET00639 | |
| 0.008 | 0.97 | 0.247 | Interleukin 2 antagonist | 0.247 0.005 DBMET00639 | DBMET00639 | |
| 0.009 | 0.971 | 0.244 | DNA polymerase I inhibitor | 0.244 0.018 DBMET00639 | DBMET00639 | |
| 0.022 | 0.985 | 0.116 | Papain-like protease (SARS coronavirus) inhibitor | 0.116 0.093 DBMET00639 | DBMET00639 | |
| 0.004 | 0.969 | 0.547 | Vasodilator | 0.547 0.009 DBMET00639 | DBMET00639 | |
| 0.008 | 0.973 | 0.111 | T cell inhibitor | 0.111 0.018 DBMET00639 | DBMET00639 | |
| 0.005 | 0.975 | 0.049 | Factor III inhibitor | 0.049 0.037 DBMET00639 | DBMET00639 | |
| 0.002 | 0.972 | 0.039 | Prostacyclin antagonist | 0.039 0.019 DBMET00639 | DBMET00639 | |
| 0.005 | 0.984 | 0.45 | Vanilloid agonist | 0.45 0.004 DBMET00639 | DBMET00639 | |
| 0.009 | 0.99 | 0.365 | Caspase 3 stimulant | 0.365 0.055 DBMET00639 | DBMET00639 | |
| 0.004 | 0.986 | 0.526 | Platelet aggregation inhibitor | 0.526 0.008 DBMET00639 | DBMET00639 | |
| 0.002 | 0.984 | 0.026 | Retinoid X gamma receptor antagonist | 0.026 0.022 DBMET00639 | DBMET00639 | |
| 0.004 | 0.988 | 0.102 | Bronchodilator | 0.102 0.062 DBMET00639 | DBMET00639 | |
| 0.001 | 0.985 | 0.099 | Squalene synthetase inhibitor | 0.099 0.006 DBMET00639 | DBMET00639 | |
| 0.005 | 0.989 | 0.616 | Immunosuppressant | 0.616 0.011 DBMET00639 | DBMET00639 | |
| 0.003 | 0.988 | 0.138 | Leukotriene synthesis inhibitor | 0.138 0.011 DBMET00639 | DBMET00639 | |
| 0.003 | 0.989 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 DBMET00639 | DBMET00639 | |
| 0.01 | 0.995 | 0.137 | Folate antagonist | 0.137 0.028 DBMET00639 | DBMET00639 | |
| 0.004 | 0.99 | 0.728 | Platelet antagonist | 0.728 0.005 DBMET00639 | DBMET00639 | |
| 0.003 | 0.989 | 0.024 | Vitamin D receptor antagonist | 0.024 0.012 DBMET00639 | DBMET00639 | |
| 0.003 | 0.99 | 0.178 | Cell adhesion molecule inhibitor | 0.178 0.011 DBMET00639 | DBMET00639 | |
| 0.003 | 0.991 | 0.16 | Neurotrophic factor | 0.16 0.051 DBMET00639 | DBMET00639 | |
| 0.004 | 0.993 | 0.596 | Immunomodulator | 0.596 0.012 DBMET00639 | DBMET00639 | |
| 0.003 | 0.991 | 0.078 | Acetyl-CoA transferase 2 inhibitor | 0.078 0.012 DBMET00639 | DBMET00639 | |
| 0.004 | 0.992 | 0.12 | Thrombolytic | 0.12 0.11 DBMET00639 | DBMET00639 | |
| 0.004 | 0.992 | 0.552 | Tumour necrosis factor alpha release inhibitor | 0.552 0.01 DBMET00639 | DBMET00639 | |
| 0.001 | 0.99 | 0.025 | Leukotriene D4 antagonist | 0.025 0.019 DBMET00639 | DBMET00639 | |
| 0.003 | 0.992 | 0.2 | Prostaglandin F2 alpha antagonist | 0.2 0.004 DBMET00639 | DBMET00639 | |
| 0.004 | 0.993 | 0.126 | Bone formation stimulant | 0.126 0.08 DBMET00639 | DBMET00639 | |
| 0.004 | 0.995 | 0.756 | Antiinflammatory | 0.756 0.022 DBMET00639 | DBMET00639 | |
| 0.003 | 0.994 | 0.236 | Cell adhesion inhibitor | 0.236 0.017 DBMET00639 | DBMET00639 | |
| 0.004 | 0.995 | 0.616 | Apoptosis antagonist | 0.616 0.008 DBMET00639 | DBMET00639 | |
| 0.004 | 0.995 | 0.367 | Cyclophilin D inhibitor | 0.367 0.111 DBMET00639 | DBMET00639 | |
| 0.001 | 0.993 | 0.051 | HMG CoA reductase inhibitor | 0.051 0.007 DBMET00639 | DBMET00639 | |
| 0.002 | 0.994 | 0.07 | Acetyl-CoA transferase 1 inhibitor | 0.07 0.007 DBMET00639 | DBMET00639 | |
| 0.003 | 0.995 | 0.558 | Hypolipemic | 0.558 0.009 DBMET00639 | DBMET00639 | |
| 0.002 | 0.995 | 0.122 | Acetyl-CoA transferase inhibitor | 0.122 0.009 DBMET00639 | DBMET00639 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |